Takip et
Özge Akbulut Çalışkan
Özge Akbulut Çalışkan
Başkent University
baskent.edu.tr üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer
O Saatci, A Kaymak, U Raza, PG Ersan, O Akbulut, CE Banister, ...
Nature communications 11 (1), 2416, 2020
2092020
Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer
Ö Saatci, S Borgoni, Ö Akbulut, S Durmuş, U Raza, E Eyüpoğlu, C Alkan, ...
Oncogene 37 (17), 2251-2269, 2018
672018
Universality of dissipative self-assembly from quantum dots to human cells
G Makey, S Galioglu, R Ghaffari, ED Engin, G Yıldırım, Ö Yavuz, O Bektaş, ...
Nature Physics 16 (7), 795-801, 2020
532020
A highly potent TACC3 inhibitor as a novel anticancer drug candidate
O Akbulut, D Lengerli, O Saatci, E Duman, UOS Seker, A Isik, A Akyol, ...
Molecular cancer therapeutics 19 (6), 1243-1254, 2020
232020
High-resolution dielectric characterization of single cells and microparticles using integrated microfluidic microwave sensors
A Secme, U Tefek, B Sari, HS Pisheh, HD Uslu, ÖA Çalışkan, ...
IEEE Sensors Journal 23 (7), 6517-6529, 2023
122023
Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification
O Saatci, O Akbulut, M Cetin, V Sikirzhytski, M Uner, D Lengerli, ...
Cell Death & Differentiation 30 (5), 1305-1319, 2023
92023
EGF-SNX3-EGFR axis drives tumor progression and metastasis in triple-negative breast cancers
E Cicek, A Circir, M Oyken, O Akbulut Caliskan, DN Dioken, ...
Oncogene 41 (2), 220-232, 2022
62022
Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancer
ME Gedik, O Saatci, N Oberholtzer, M Uner, O Akbulut, M Cetin, M Aras, ...
bioRxiv, 2023
22023
Abstract PO4-24-04: Identifying the interactome of TACC3, a major driver in aggressive cancer cells with centrosome amplification
O Saatci, O Akbulut, M Cetin, V Sikirzhytski, M Uner, D Lengerli, ...
Cancer Research 84 (9_Supplement), PO4-24-04-PO4-24-04, 2024
2024
Abstract LB275: Reactivation of mitotic arrest upon targeting TACC3 restores immunogenic cell death and T-DM1 response in HER2-positive breast cancer
O Saatci, ME Gedik, N Oberholtzer, M Uner, O Akbulut, M Cetin, M Aras, ...
Cancer Research 84 (7_Supplement), LB275-LB275, 2024
2024
Highly potent TACC3 inhibitor as a novel anticancer drug candidate
E Banoglu, B Caliskan, O Sahin, D Lengerli, O Akbulut
US Patent 11,622,966, 2023
2023
Novel bi-thiazole LOX inhibitors to overcome chemotherapy resistance in triple negative breast cancer
M Cetin, O Saatci, AH Rezaeian, O Akbulut, NR Chintada, H Taylor, ...
Cancer Research 83 (7_Supplement), 578-578, 2023
2023
Inhibition of TACC3 blocks the growth of highly aggressive breast cancers with centrosome amplification
O Saatci, O Akbulut, M Cetin, V Sikirzhytski, O Sahin
Cancer Research 83 (7_Supplement), 5728-5728, 2023
2023
Abstract P4-08-20: Inhibition of TACC3 blocks the growth of highly aggressive breast cancers with centrosome amplification
O Saatci, O Akbulut, M Cetin, V Sikirzhytski, O Sahin
Cancer Research 83 (5_Supplement), P4-08-20-P4-08-20, 2023
2023
Abstract P6-10-18: Developing novel lysyl oxidase (LOX) inhibitors to overcome chemotherapy resistance in triple negative breast cancer
M Cetin, O Saatci, O Akbulut, C Beneker, AH Rezaeian, M Chernov, ...
Cancer Research 83 (5_Supplement), P6-10-18-P6-10-18, 2023
2023
Isoxazole derivatives targeting tacc3 as anticancer agents
E Banoglu, B Caliskan, O Sahin, D Lengerli, O Akbulut, LIM Chaemin, ...
US Patent App. 17/776,767, 2023
2023
Abstract LT015: Overcoming chemotherapy resistance in triple negative breast cancer via targeting lysyl oxidase (LOX)
O Saatci, O Akbulut, AH Rezaeain, C Banister, V Sikirzhytski, S Aksoy, ...
Cancer Research 81 (5_Supplement), LT015-LT015, 2021
2021
Microfluidics-Integrated Microwave Sensors for Single Cells Size Discrimination
A Secme, HS Pisheh, HD Uslu, O Akbulut, RT Erdogan, MS Hanay
2020 IEEE MTT-S International Microwave Biomedical Conference (IMBioC), 1-3, 2020
2020
A novel TACC3 inhibitor as an anti-cancer agent in breast cancer
O Akbulut, D Lengerli, O Saatci, E Duman, U Seker, B Caliskan, ...
Cancer Research 79 (13_Supplement), 3871-3871, 2019
2019
Physics of Cancer Metastasis
S Galigolu, O Akbulut, R Ghaffari, T Ozcelik, O Sahin, S Ilday
APS March Meeting Abstracts 2019, K66. 005, 2019
2019
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20